Cargando…
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
Deregulation of aerobic glycolysis is a common phenomenon in human cancers, including glioblastoma (GBM). In the present study, we demonstrated that the natural compound xanthohumol has a profound anti-tumor effect on GBM via direct inhibition of glycolysis. Xanthohumol suppressed cell proliferation...
Autores principales: | Yuan, Jian, Peng, Gang, Xiao, Gelei, Yang, Zhuanyi, Huang, Jun, Liu, Qing, Yang, Zhiquan, Liu, Dingyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196271/ https://www.ncbi.nlm.nih.gov/pubmed/32368287 http://dx.doi.org/10.7150/jca.33045 |
Ejemplares similares
-
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
por: Liu, Wenbin, et al.
Publicado: (2019) -
High LAMC1 expression in glioma is associated with poor prognosis
por: Liu, Jian, et al.
Publicado: (2019) -
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
por: Wolf, Amparo, et al.
Publicado: (2011) -
MicroRNA-202 suppresses glycolysis of pancreatic cancer by targeting hexokinase 2
por: Wang, Shuang-Jia, et al.
Publicado: (2021) -
Side of Lesions Predicts Surgical Outcomes in Patients With Drug-Resistant Temporal Lobe Epilepsy Secondary to Focal Cortical Dysplasia Type IIIa
por: He, Xinghui, et al.
Publicado: (2020)